Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 1R18HS017093-01 | U.S. AHRQ Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Agency for Healthcare Research and Quality (AHRQ) | FED |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will use a factorial design randomized controlled trial to (1)compare multi-faceted decision support (intervention) to streamlined clinical alerts (control) and (2) evaluate whether collecting information about women's risk of pregnancy using a networked tablet computer (intervention) is superior to the way clinicians usually collect this information (control).
Over the course of 1 year, we will abstract data from the electronic medical record when study clinicians prescribe teratogenic medications, conduct phone interviews with women prescribed medications by participating clinicians, and survey participating clinicians about their satisfaction with the decision support they receive. We will use this data to confirm our hypotheses that clinicians in the intervention groups will (1) prescribe fewer teratogenic medications, (2) be more likely to prescribe contraception when a teratogenic medication is prescribed, (3) have more patients report satisfaction with the counseling they received, and (4) report more satisfaction with the decision support they received.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| multi-faceted decision support | Experimental | Multi-faceted decision support |
|
| control | Active Comparator | stream-lined clinical alert |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Clinical decision support | Other | multi-faceted decision support |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of women prescribed potentially teratogenic medications with documented use of contraception | 1 year |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Eleanor B Schwarz, MD, MS | University of Pittsburgh | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Partners in Health | Delmont | Pennsylvania | 15626 | United States | ||
| Partners in Health |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 22297687 | Derived | Schwarz EB, Parisi SM, Handler SM, Koren G, Cohen ED, Shevchik GJ, Fischer GS. Clinical decision support to promote safe prescribing to women of reproductive age: a cluster-randomized trial. J Gen Intern Med. 2012 Jul;27(7):831-8. doi: 10.1007/s11606-012-1991-y. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000014 | Abnormalities, Drug-Induced |
| ID | Term |
|---|---|
| D000013 | Congenital Abnormalities |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| stream-lined clinical alert |
| Other |
electronic notification that a medication is potentially teratogenic |
|
| Level Green |
| Pennsylvania |
| 15085 |
| United States |
| Partners in Health | Murrysville | Pennsylvania | 15085 | United States |
| General Internal Medicine Oakland (GIMO) Practice | Pittsburgh | Pennsylvania | 15213 | United States |